{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:14:34Z","timestamp":1792588474281,"version":"4.5.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background\/Objective<\/jats:title>\n                    <jats:p>Cisplatin is a popular platinum-containing chemotherapeutic agent that has been used clinically since the 1970s to manage a wide range of hematologic and solid tumors. However, its therapeutic purpose is restricted by significant dose-related toxicities, particularly nephrotoxicity and gastrointestinal damage. Therefore, the present study assesses the potential protective effects of vonoprazan (a potassium-competitive acid blocker) against cisplatin-provoked organ damage, in addition to examining the impacts of vonoprazan on the antineoplastic activity of cisplatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Rats were pretreated with vonoprazan (10 or 20\u00a0mg\/kg) in an\n                      <jats:italic>in vivo<\/jats:italic>\n                      study, and their renal, gastric, and intestinal injuries were assessed using spectrophotometric assays, enzyme-linked immunosorbent assay (ELISA), and immunohistochemical (IHC) analysis. Moreover, the oxidative stress, inflammatory, autophagic, and apoptotic pathways were evaluated. Then, MCF-7 human breast cancer cells were treated with cisplatin alone or in combination with vonoprazan in an\n                      <jats:italic>in vitro<\/jats:italic>\n                      study, and the cell viability, combination index, and apoptosis-related markers were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>in vivo<\/jats:italic>\n                      study showed that vonoprazan pre-administration meaningfully lowered the injurious influences of cisplatin on the kidney, stomach, and intestine, as evidenced by improvements in the histopathological changes and decreased levels of serum lactate dehydrogenase (LDH), serum creatinine (sCr), and blood urea nitrogen (BUN). Vonoprazan boosted the antioxidant defenses by increasing the total antioxidant capacity (TAC) and decreasing the malondialdehyde (MDA) levels in the kidney, stomach, and intestinal tissues. Moreover, vonoprazan decreased the early biomarkers of acute kidney injury (KIM-1 and NGAL), improved the gastroprotective mediators (increased cGMP and PGI2; decreased serotonin), and modulated the intestinal epithelial and mucosal injury markers (increased TFF3; decreased IFABP). Vonoprazan also attenuated the inflammasome component (NLRP3) and inflammatory signaling mediators (NF-\u03baB and IL-6) while modulating the autophagy-lysosomal pathway (enhanced LC3 and Beclin-1; decreased p62). However, the\n                      <jats:italic>in vitro<\/jats:italic>\n                      study results revealed that the combination of cisplatin and vonoprazan had a synergistic cytotoxic effect and an enhancing effect on the apoptotic pathway (increased p53 and BAX; decreased BCL2).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vonoprazan attenuates cisplatin-induced organ injury while augmenting its anticancer effects; this suggests the potential of vonoprazan as a supportive therapeutic strategy during cisplatin-based chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1798103","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:42:01Z","timestamp":1777534921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Vonoprazan as an adjuvant to cisplatin: enhancing antitumor efficacy while mitigating nephrotoxicity and gastrointestinal adverse effects"],"prefix":"10.3389","volume":"17","author":[{"given":"Faiz N.","family":"Alenezi","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa E.","family":"Abdelmageed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura National University","place":["Gamasa, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar A.","family":"Nader","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura National University","place":["Gamasa, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.","family":"Zaghloul","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura National University","place":["Gamasa, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","article-title":"NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases","volume":"4","author":"Abderrazak","year":"2015","journal-title":"Redox Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"44412","DOI":"10.1007\/s11356-020-10351-9","article-title":"The protective efficacy of vitamin E and cod liver oil against cisplatin-induced acute kidney injury in rats","volume":"27","author":"Abo-Elmaaty","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/ph15111436","article-title":"Fasudil ameliorates methotrexate-induced hepatotoxicity by modulation of redox-sensitive signals","volume":"15","author":"Aboubakr","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1139\/cjpp-2017-0751","article-title":"Combined but not single administration of vitamin C and l-carnitine ameliorates cisplatin-induced gastric mucosa damage in male rats","volume":"96","author":"Adefisayo","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00001813-199404000-00008","article-title":"Cisplatin-induced peptic ulcers, vagotomy, adrenal and calcium modulation","volume":"5","author":"Aggarwal","year":"1994","journal-title":"Anticancer Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00210-021-02097-z","article-title":"The salutary action of melatonin and betaine, given singly or concomitantly, on cisplatin-induced nephrotoxicity in mice","volume":"394","author":"Al Za'abi","year":"2021","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12882-017-0601-y","article-title":"Protective effect of rutin supplementation against cisplatin-induced nephrotoxicity in rats","volume":"18","author":"Alhoshani","year":"2017","journal-title":"BMC Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1038\/s41467-019-12315-1","article-title":"TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths","volume":"10","author":"Belle","year":"2019","journal-title":"Nat. Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1093\/ndt\/gfp010","article-title":"Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more","volume":"24","author":"Bonventre","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"B11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2982.2010.01483.x","article-title":"Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica","volume":"22","author":"Cabezos","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"B12","doi-asserted-by":"publisher","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome","volume":"303","author":"Camilleri","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4049\/jimmunol.164.2.966","article-title":"Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors","volume":"164","author":"Cario","year":"2000","journal-title":"J. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.2147\/DDDT.S276704","article-title":"In vitro and in vivo rat model assessments of the effects of vonoprazan on the pharmacokinetics of venlafaxine","volume":"14","author":"Chen","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.intimp.2018.04.006","article-title":"Oregonin inhibits inflammation and protects against barrier disruption in intestinal epithelial cells","volume":"59","author":"Chi","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"B18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr. Cancer Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1517\/14656566.6.7.1049","article-title":"Proton pump inhibitors may reduce tumour resistance","volume":"6","author":"De Milito","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2014.02.030","article-title":"Pharmacological evidence for the participation of NO-cGMP-KATP pathway in the gastric protective effect of curcumin against indomethacin-induced gastric injury in the rat","volume":"730","author":"D\u00edaz-Triste","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00204-007-0262-x","article-title":"Resveratrol attenuates cisplatin-induced nephrotoxicity in rats","volume":"82","author":"Do Amaral","year":"2008","journal-title":"Arch. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0162-3109(93)90042-o","article-title":"Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells","volume":"26","author":"Eisenhut","year":"1993","journal-title":"Immunopharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.18502\/ijph.v50i5.6121","article-title":"The synergistic combination of cisplatin and piperine induces apoptosis in MCF-7 cell line","volume":"50","author":"Fattah","year":"2021","journal-title":"Iran. J. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S365","DOI":"10.4103\/0973-1296.210176","article-title":"In vitro cell viability by CellProfiler(\u00ae) software as equivalent to MTT assay","volume":"13","author":"Gasparini","year":"2017","journal-title":"Pharmacogn. Mag."},{"key":"B26","article-title":"Cisplatin","volume-title":"StatPearls [Internet]","author":"Gold","year":"2023"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e00895","DOI":"10.1002\/prp2.895","article-title":"The abrupt pathological deterioration of cisplatin-induced acute kidney injury: emerging of a critical time point","volume":"9","author":"Gong","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B85","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/27.8.90074","article-title":"The use of avidin-biotin interaction in immunoenzymatic techniques","volume":"27","author":"Guesdon","year":"1979","journal-title":"J. Histochem. Cytochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2003.03.024","article-title":"Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma","volume":"21","author":"Gupta","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/s0022-2143(99)90185-3","article-title":"Antithrombin prevents stress-induced gastric mucosal injury by increasing the gastric prostacyclin level in rats","volume":"133","author":"Isobe","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI117676","article-title":"A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion","volume":"95","author":"Jung","year":"1995","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"17981","DOI":"10.1007\/s00210-025-04419-x","article-title":"Hesperidin provides dose-dependent renal protection from cisplatin-induced injury, mediated by its regulation of beclin-1 and LC3-II","volume":"398","author":"Kahkesh","year":"2025","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4161\/auto.4615","article-title":"Cytosolic LC3 ratio as a sensitive index of macroautophagy in isolated rat hepatocytes and H4-II-E cells","volume":"3","author":"Karim","year":"2007","journal-title":"Autophagy"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.taap.2011.11.013","article-title":"Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53","volume":"258","author":"Khan","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6265307","DOI":"10.1155\/2019\/6265307","article-title":"Kidney injury molecule 1 (KIM-1) as an early predictor for acute kidney injury in post-cardiopulmonary bypass (CPB) in open heart surgery patients","volume":"2019","author":"Khreba","year":"2019","journal-title":"Int. J. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"143945","DOI":"10.1016\/j.gene.2019.143945","article-title":"Characterization of a catalase from red-lip mullet (Liza haematocheila): demonstration of antioxidative activity and mRNA upregulation in response to immunostimulants","volume":"712","author":"Kim","year":"2019","journal-title":"Gene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1267254","DOI":"10.3389\/fphar.2023.1267254","article-title":"The effect of ginger extract on cisplatin-induced acute anorexia in rats","volume":"14","author":"Kim","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/antiox10081163","article-title":"Immunohistochemical analysis of 4-HNE, NGAL, and HO-1 tissue expression after apocynin treatment and HBO preconditioning in postischemic acute kidney injury induced in spontaneously hypertensive rats","volume":"10","author":"Kovacevic","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e23372","DOI":"10.1002\/jbt.23372","article-title":"Clemizole hydrochloride, a potent TRPC5 calcium channel inhibitor, prevents cisplatin-induced nephrotoxicity in Sprague-Dawley rats","volume":"37","author":"Kuma\u015f-Kulualp","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2886268","DOI":"10.1155\/2020\/2886268","article-title":"Noninvasive biomarkers of gut barrier function in patients suffering from diarrhea predominant-IBS: an update","volume":"2020","author":"Linsalata","year":"2020","journal-title":"Dis. Markers"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3892\/ol.2017.7665","article-title":"Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs","volume":"96","author":"Luciani","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"B45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejphar.2006.10.043","article-title":"Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats","volume":"555","author":"Malik","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2014.12.008","article-title":"Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis","volume":"748","author":"Malik","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e13499","DOI":"10.1111\/nmo.13499","article-title":"Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron","volume":"31","author":"Mart\u00edn-Ru\u00edz","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"B48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1091581813493013","article-title":"Time course of renal proximal tubule injury, reversal, and related biomarker changes in rats following cisplatin administration","volume":"32","author":"McDuffie","year":"2013","journal-title":"Int. J. Toxicol."},{"key":"B84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bjp.0707605","article-title":"Role of the NO\/cGMP\/KATP pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats","volume":"153","author":"Medeiros","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1038\/s41598-018-34156-6","article-title":"The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K\/Akt and p53 signaling pathways","volume":"8","author":"Mi","year":"2018","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1248\/bpb.19.318","article-title":"Effect of cisplatin on the disposition of endogenous serotonin and its main metabolite, 5-hydroxyindole-3-acetic acid, in rats and dogs","volume":"19","author":"Nakajima","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.3390\/cells10112828","article-title":"NLRP3 activation and its relationship to endothelial dysfunction and oxidative stress: implications for preeclampsia and pharmacological interventions","volume":"10","author":"Nunes","year":"2021","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4320374","DOI":"10.1155\/2016\/4320374","article-title":"Plant-derived agents for counteracting cisplatin-induced nephrotoxicity","volume":"2016","author":"Ojha","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"967826","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e64777","DOI":"10.7759\/cureus.64777","article-title":"A comprehensive review on the efficacy and safety of vonoprazan in the management of gastric acid-related diseases","volume":"16","author":"Padwale","year":"2024","journal-title":"Cureus"},{"key":"B58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","article-title":"Fatty acid-binding proteins as plasma markers of tissue injury","volume":"352","author":"Pelsers","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"B59","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ki.2008.214","article-title":"Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells","volume":"74","author":"Periyasamy-Thandavan","year":"2008","journal-title":"Kidney Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1462802","DOI":"10.1155\/2018\/1462802","article-title":"Cisplatin-induced rodent model of kidney injury: characteristics and challenges","volume":"2018","author":"Per\u0161e","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B61","first-page":"265","article-title":"A radical view of the stomach: the role of oxygen-derived free radicals and anti-oxidants in gastroduodenal disease","volume":"7","author":"Phull","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0006-2952(98)00333-5","article-title":"Inhibition of oxidant-induced barrier disruption and protein tyrosine phosphorylation in Caco-2 cell monolayers by epidermal growth factor","volume":"57","author":"Rao","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4292\/wjgpt.v9.i7.63","article-title":"Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?","volume":"9","author":"Rawla","year":"2018","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-018-3420-y","article-title":"Mangiferin attenuates cisplatin-induced acute kidney injury in rats mediating modulation of MAPK pathway","volume":"452","author":"Sahu","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12011-018-1457-0","article-title":"Protective effect of nanoceria on cisplatin-induced nephrotoxicity by amelioration of oxidative stress and pro-inflammatory mechanisms","volume":"189","author":"Saifi","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00436-025-08526-9","article-title":"The therapeutic effects of vonoprazan against giardiasis in rats: parasitological, pathological, and immunological aspects","volume":"124","author":"Sallam","year":"2025","journal-title":"Parasitol. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/jphp.12654","article-title":"Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesis","volume":"69","author":"Sharifat","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"351","DOI":"10.15171\/apb.2015.049","article-title":"Doxorubicin changes Bax\/Bcl-xL ratio, Caspase-8 and 9 in breast cancer cells","volume":"5","author":"Sharifi","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"B69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s1382-6689(96)00137-8","article-title":"Effect of antioxidants on cisplatin induced delay in gastric emptying in rats","volume":"3","author":"Sharma","year":"1997","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"G137","DOI":"10.1152\/ajpgi.00057x.2002","article-title":"ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in Guinea pig gastric myocytes","volume":"282","author":"Sim","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-9966-29-44","article-title":"Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy","volume":"29","author":"Spugnini","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1756283x17745776","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date","volume":"11","author":"Sugano","year":"2018","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"108647","DOI":"10.1016\/j.biopha.2019.108647","article-title":"Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: impact on inflammation, apoptosis, and autophagy","volume":"112","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ajpath.2011.11.001","article-title":"Autophagy guards against cisplatin-induced acute kidney injury","volume":"180","author":"Takahashi","year":"2012","journal-title":"Am. J. Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drup.2015.08.004","article-title":"Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach","volume":"23","author":"Taylor","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"B76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00383-010-2798-8","article-title":"Protective mechanism of glutamine on the expression of proliferating cell nuclear antigen after cisplatin-induced intestinal mucosal injury","volume":"27","author":"Tazuke","year":"2011","journal-title":"Pediatr. Surg. Int."},{"key":"B77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopha.2008.08.004","article-title":"Role of glutathione S-transferase PI in cisplatin-induced nephrotoxicity","volume":"63","author":"Townsend","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.aca.2016.10.014","article-title":"High-resolution laser ablation-inductively coupled plasma-mass spectrometry imaging of cisplatin-induced nephrotoxic side effects","volume":"945","author":"Van Acker","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00221-014-3954-5","article-title":"X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin","volume":"232","author":"Vera","year":"2014","journal-title":"Exp. Brain Res."},{"key":"B80","first-page":"341","article-title":"Effects of various autophagy modulators on the expression of autophagic markers LC3II and p62","volume":"49","author":"Wei","year":"2018","journal-title":"J. China Pharm. Univ."},{"key":"B81","doi-asserted-by":"publisher","first-page":"276186","DOI":"10.1155\/2013\/276186","article-title":"Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats","volume":"2013","author":"Yamamoto","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 inflammasome and inflammatory bowel disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/13880209.2023.2173253","article-title":"Assessments of CYP-inhibition-based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo","volume":"61","author":"Zhou","year":"2023","journal-title":"Pharm. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1798103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:42:06Z","timestamp":1777534926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1798103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":85,"alternative-id":["10.3389\/fphar.2026.1798103"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1798103","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1798103"}}